Oslo University Hospital-ko ikertzaileekin lankidetzan egindako argitalpenak (11)

2023

  1. Analysis of ATG4C function in vivo

    Autophagy, Vol. 19, Núm. 11, pp. 2912-2933

2021

  1. Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1

    Autophagy, Vol. 17, Núm. 1, pp. 1-382

2020

  1. Improved cardiovascular risk prediction in patients with end-stage renal disease on hemodialysis using machine learning modeling and circulating microribonucleic acids

    Theranostics, Vol. 10, Núm. 19, pp. 8665-8676

2019

  1. Catalyzing transcriptomics research in cardiovascular disease: The CardioRNA COST action CA17129

    Non-coding RNA, Vol. 5, Núm. 2

2016

  1. Erratum to: Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition) (Autophagy, 12, 1, 1-222, 10.1080/15548627.2015.1100356

    Autophagy

  2. Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition)

    Autophagy, Vol. 12, Núm. 1, pp. 1-222

2015

  1. Pancreatic cancer exosomes initiate pre-metastatic niche formation in the liver

    Nature Cell Biology, Vol. 17, Núm. 6, pp. 816-826

2012

  1. Guidelines for the use and interpretation of assays for monitoring autophagy

    Autophagy, Vol. 8, Núm. 4, pp. 445-544

2011

  1. MicroRNA profiles of t(14;18)-negative follicular lymphoma support a late germinal center B-cell phenotype

    Blood, Vol. 118, Núm. 20, pp. 5550-5558

2008

  1. Guidelines for the use and interpretation of assays for monitoring autophagy in higher eukaryotes

    Autophagy, Vol. 4, Núm. 2, pp. 151-175

2005

  1. CDK4 and MDM2 gene alterations mainly occur in highly proliferative and aggressive mantle cell lymphomas with wild-type INK4a/ARF locus

    Cancer Research, Vol. 65, Núm. 6, pp. 2199-2206